LivaNova (Nasdaq:LIVN) today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary ...

The aura6000 is an implantable hypoglossal neurostimulator intended to treat adult patients with moderate to severe obstructive sleep apnea (OSA ... data to the U.S. Food and Drug Administration (FDA) ...

Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive ...

Detailed price information for Inspire Medical Systems Inc (INSP-N) from The Globe and Mail including charting and trades.

It's been more than a year since Apple Watch Ultra 2 launched, and we've had the wearable that's only gotten better on our ...

The multinational tech giant Apple have filed a patent application for a head-mounted device (HMD) with a posture monitoring ...

Adidas sale: deals from $5 @ Amazon The Adidas Store at Amazon is offering a wide variety of Black Friday deals on men's/women's/children's sweat pants, hoodies, socks, and more. After discount, deals ...

Oral semaglutide 25 mg is not currently FDA-approved for weight management ... thyroid disease, and obstructive sleep apnea.

Key TakeawaysLLY has declined 10.6% this month after disappointing third-quarter results.The drug maker has seen strong ...

13" iPad Pro (Wi-Fi/256GB): was $1,299 now $1,194 @ Amazon The ultimate iPad Pro is now on sale. Featuring a 13-inch (2,752 x ...

Additionally, Quince was granted Fast Track designation by the FDA for the company's EryDex System for the ... its OSPREY randomized controlled trial (RCT), Treating Obstructive Sleep Apnea Using ...

Poseida Therapeutics, Inc. , a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer, autoimmune and rare diseases ...